STAMPEDE otherwise follows a line of randomized trials (e.g., MAST, TAXOMET, IMPROVE) that have failed to prove cancer ...

Pfizer (PFE) stock in focus as Sally Susman, the company's Chief Corporate Affairs Officer, plans to depart after 18 years.

Pfizer Inc. closed 18.77% short of its 52-week high of $31.54, which the company achieved on July 30th.

Changing market conditions and consumer tastes and preferences have weighed on these businesses. Investors can learn a lot ...

One of the best known communications executives in corporate America, Susman worked at Pfizer for nearly two decades after ...

Discover why options trading trends, robust R&D, and strong free cash flow position Pfizer Inc. for growth. Click for my ...

According to Bloomberg, citing an email sent by Chief Executive Officer Albert Bourla on Tuesday, Susman’s responsibilities ...

The Justice Department changed its policy on foreign corruption cases, which might have put an end to investigations into the ...

At recent prices, the yield you receive from Pfizer is more than four times the amount you'd receive from the average ...

The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...

Pfizer recently announced positive results from the BASIS study, the global phase 3 trial evaluating Hympavzi in young adults ...

In the latest close session, Pfizer (PFE) was up +1.51% at $25.62. The stock's performance was ahead of the S&P 500's daily loss of 0.07%. Elsewhere, the Dow saw a downswing of 0.37%, while the ...